1. Deutsch A, Chaimovitzch C, Nagauker-Shriker O, Zlotnik M, Shany S, Levy R. Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3: changes in kinetics and in oxidase cytosolic factor p47. J Am Soc Nephrol. 1995;6(1):102-109.
2. Silverman WF, Alfahel-Kakunda A, Dori A, Barker JL. Separation of dorsal and ventral dopaminergic neurons from embryonic rat mesencephalon by buoyant density fractionation: disassembling pattern in the ventral midbrain. J Neurosci Methods. 1999;89(1):1-8.
3. Dori A, Maric D, Maric I, Masalha R, Barker JL, Silverman WF. Striatal matrix neurons of the rat differentiate in culture from dissociated fetal progenitor cells isolated by buoyant density centrifugation. Neurosci Lett. 2000;282(1-2):77-80.
4. Sekler I, Moran A, Hershfinkel M, Dori A, Margulis A, Birenzweig N, Nitzan Y, Silverman WF. Distribution of the zinc transporter ZnT-1 in comparison with chelatable zinc in the mouse brain. J Comp Neurol. 2002;447(3):201-209.
5. Meshorer E, Toiber D, Zurel D, Sahly I, Dori A, Cagnano E, Schreiber L, Grisaru D, Tronche F, Soreq H. Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products. J Biol Chem. 2004;279(28):29740-29751.
6. Dori A, Cohen J, Silverman WF, Pollack Y, Soreq H. Functional manipulations of acetylcholinesterase splice variants highlight alternative splicing contributions to murine neocortical development. Cereb Cortex. 2005;15(4):419-430.
7. Meshorer E, Bryk B, Toiber D, Cohen J, Podoly E, Dori A, Soreq H. SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Mol Psychiatry. 2005;10(11):985-997.
8. Dori A, Soreq H. Neuromuscular therapeutics by RNA-targeted suppression of ACHE gene expression. Ann N Y Acad Sci. 2006;1082:77-90.
9. Dori A, Soreq H. ARP, the cleavable C-terminal peptide of "readthrough" acetylcholinesterase, promotes neuronal development and plasticity. J Mol Neurosci. 2006;28(3):247-255.
10. Medvdovsky M, Ifergane G, Wirguin I, Vander T, Dori A, Kipervasser S, Shifrin A, Vakhapova-Danicek V, Neufeld MY. Traumatic intracranial hemorrhage in patients with seizures: descriptive characteristics. Epilepsy Behav. 2006;8(2):429-433.
11. Dori A, Ifergane G, Saar-Levy T, Bersudsky M, Mor I, Soreq H, Wirguin I. Readthrough acetylcholinesterase in inflammation-associated neuropathies. Life Sci. 2007;80(24-25):2369-2374.
12. Cohen JE, Zimmerman G, Melamed-Book N, Friedman A, Dori A, Soreq H. Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells. Hippocampus. 2008;18(2):182-192.
13. Lidar M, Dori A, Levy Y, Lidar Z, Chapman J, Langevitz P. Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review. Clin Rev Allergy Immunol. 2010;38(2-3):270-275.
14. Livneh U, Dori A, Katzav A, Kofman O. Strain and regional dependence of alternate splicing of acetylcholinesterase in the murine brain following stress or treatment with diisopropylfluorophosphate. Behav Brain Res. 2010;210(1):107-115.
15. Auriel E, Regev K, Dori A, Karni A. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve. 2011;43(6):893-894.
16. Dori A, Oriel S, Livneh U, Duek O, Lin T, Kofman O. Acetylcholinesterase inhibitor pretreatment alters stress-induced expression of acetylcholinesterase transcripts in the mouse brain. Neuroscience. 2011;183:90-98.
17. Lin T, Duek O, Dori A, Kofman O. Differential long term effects of early diisopropylfluorophosphate exposure in Balb/C and C57Bl/J6 mice. Int J Dev Neurosci. 2012;30(2):113-120.
18. Maggio N, Shavit-Stein E, Dori A, Blatt I, Chapman J. Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones. Frontiers in molecular neuroscience. 2013;6:46.
19. Dori A, Lopate G, Keeling R, Pestronk A. Myovascular innervation: Axon loss in small fiber neuropathies. Muscle and Nerve. 2014.
